CoverageForm 410-K10-Q8-K13D13G13F

NVST · Envista Holdings Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · NVST

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$2.72B$2.51B$2.57B$2.57B$2.51B$2.28B
Cost of Revenue$1.23B$1.14B$1.13B$1.09B$1.08B$1.12B
Gross Profit$1.49B$1.37B$1.44B$1.47B$1.43B$1.16B
R&D$114.00M$99.10M$93.80M$100.10M$100.50M$100.80M
SG&A$1.16B$1.16B$1.06B$1.06B$1.02B$1.02B
Total Operating Expenses-$2.27B----
D&A$116.00M$123.10M$135.60M$137.80M$117.80M$132.60M
Operating Income$216.10M($1.04B)$31.50M$319.20M$306.20M$33.30M
Interest Expense--$63.40M$38.40M$54.10M$62.50M
Income Tax$130.20M$33.90M$45.30M$45.90M($9.00M)($63.40M)
Net Income$47.00M($1.12B)($100.20M)$243.10M$340.50M$33.30M
EPS - Basic$0.28($6.50)($0.60)$1.49$2.11$0.21
EPS - Diluted$0.28($6.50)($0.60)$1.37$1.92$0.20

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$1.21B$1.07B$940.00M$606.90M$1.07B$888.90M
Accounts Receivable$429.60M$363.00M$407.50M$393.50M$331.90M$361.00M
Inventory$288.10M$241.00M$258.80M$300.80M$263.80M$266.90M
Accounts Payable$191.60M$174.60M$179.50M$228.30M$185.80M$235.10M
Current Assets$2.03B$1.79B$1.74B$1.42B$1.84B$1.59B
Total Assets$5.68B$5.35B$6.61B$6.59B$6.57B$6.88B
Current Liabilities$852.60M$878.70M$780.80M$1.24B$1.21B$1.68B
Long-term Debt$1.45B$1.28B$1.40B$870.70M$883.40M$907.70M
Total Liabilities------
Stockholders' Equity$3.11B$2.93B$4.17B$4.21B$4.06B$3.72B
Retained Earnings($440.40M)($487.40M)$631.20M$731.40M$466.90M$126.40M

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$275.70M$336.50M$275.70M$182.70M$361.60M$283.90M
Investing Cash Flow($51.10M)($54.60M)($62.40M)($657.30M)$262.70M($69.10M)
Financing Cash Flow($170.90M)($103.70M)$118.90M$12.50M($465.60M)$492.50M
CapEx$45.30M$33.80M$58.20M$75.70M$54.70M$47.70M
Free Cash Flow$230.40M$302.70M$217.50M$107.00M$306.90M$236.20M

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin54.7%54.7%56.1%57.4%56.9%50.7%
Operating margin7.9%-41.4%1.2%12.4%12.2%1.5%
EBITDA margin12.2%-36.4%6.5%17.8%16.9%7.3%
Net margin1.7%-44.6%-3.9%9.5%13.6%1.5%
Free cash flow margin8.5%12.1%8.5%4.2%12.2%10.4%
FCF / Net income4.90-0.27-2.170.440.907.09
R&D / Revenue4.2%3.9%3.7%3.9%4.0%4.4%
SG&A / Revenue42.5%46.1%41.2%41.1%40.6%44.9%
Effective tax rate73.5%--15.9%-2.7%-
Return on assets0.8%-20.9%-1.5%3.7%5.2%0.5%
Return on equity1.5%-38.1%-2.4%5.8%8.4%0.9%
Return on invested capital2.4%-19.5%0.4%5.3%6.2%0.6%
Liquidity
Current ratio2.382.042.231.151.520.94
Quick ratio2.041.761.900.911.300.79
Cash ratio1.421.221.200.490.890.53
Leverage
Debt / Equity0.470.440.330.210.220.24
Debt / Assets0.260.240.210.130.130.13
Debt / EBITDA4.36-8.371.912.085.47
Interest coverage--0.5x8.3x5.7x0.5x
Equity multiplier1.831.821.581.571.621.85
Liabilities / Assets------
Efficiency
Asset turnover0.480.470.390.390.380.33
Inventory turnover4.284.724.353.644.104.21
Days sales outstanding58d53d58d56d48d58d
Days inventory outstanding85d77d84d100d89d87d
Days payable outstanding57d56d58d76d63d76d
Cash conversion cycle86d74d84d80d75d68d
Valuation
P / E77.5x--24.6x23.5x168.6x
P / B1.2x1.1x1.0x1.4x2.0x1.5x
P / S1.4x1.3x1.6x2.3x3.2x2.4x
EV / EBITDA11.8x-26.8x13.7x18.4x33.5x
Growth
Revenue growth (YoY)8.3%-2.2%-0.1%2.4%9.9%-18.8%
Revenue CAGR (3y)1.9%0.0%4.0%-3.0%--
Revenue CAGR (5y)3.6%-2.2%----
Gross profit growth (YoY)8.3%-4.7%-2.3%3.4%23.2%-28.6%
Operating income growth (YoY)---90.1%4.2%819.5%-88.8%
Net income growth (YoY)--1016.4%--28.6%922.5%-88.9%
EPS growth (YoY)--983.3%--28.6%860.0%-91.5%
EPS CAGR (3y)-41.1%---16.5%--
EPS CAGR (5y)7.0%-----
FCF growth (YoY)-23.9%39.2%103.3%-65.1%29.9%-17.7%
FCF CAGR (5y)-0.5%1.1%----
Book value growth (YoY)5.8%-29.7%-0.8%3.7%9.1%5.1%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$2.72B total
Specialty Productsand Technologies$1.75B · 64.5%
Equipmentand Consumables$966.70M · 35.5%

Geographic

$4.47B total
US$1.28B · 28.6%
All Other Countries$1.24B · 27.8%
North America$720.50M · 16.1%
Western Europe$498.00M · 11.1%
High Growth Markets$444.80M · 9.9%
CN$194.40M · 4.3%
Other Developed Markets$89.50M · 2.0%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

7/9
Strong
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Dental Equipment & Supplies

CompanyRevenue (last FY)Net marginROE
XRAY$3.68B-16.3%-44.7%
ZIMV---
SONX$33.20M-84.4%-540.0%
SDC---
BIOL---

Comparing Envista Holdings Corp against the 5 most active filers in the same SIC group.